Lantheus (LNTH) Short Interest Ratio & Short Volume → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free LNTH Stock Alerts $64.21 -0.20 (-0.31%) (As of 01:22 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Lantheus Short Interest DataCurrent Short Volume4,720,000 sharesPrevious Short Volume5,180,000 sharesChange Vs. Previous Month-8.88%Dollar Volume Sold Short$293.77 millionShort Interest Ratio / Days to Cover4.3Last Record DateMarch 31, 2024Outstanding Shares68,551,000 sharesFloat Size66,920,000 sharesShort Percent of Float7.05%Today's Trading Volume195,041 sharesAverage Trading Volume1,036,940 sharesToday's Volume Vs. Average19% Short Selling Lantheus ? Sign up to receive the latest short interest report for Lantheus and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLNTH Short Interest Over TimeLNTH Days to Cover Over TimeLNTH Percentage of Float Shorted Over Time Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. Lantheus Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,720,000 shares $293.77 million -8.9%7.1%4.3 $62.24 3/15/20245,180,000 shares $301.32 million -0.8%7.7%4.5 $58.17 2/29/20245,220,000 shares $341.28 million +3.8%7.8%3.8 $65.38 2/15/20245,030,000 shares $290.48 million +2.9%7.5%3.6 $57.75 1/31/20244,890,000 shares $253.94 million -11.4%7.3%3.8 $51.93 1/15/20245,520,000 shares $310.44 million +5.8%8.2%4.2 $56.24 Get the Latest News and Ratings for LNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantheus and its competitors with MarketBeat's FREE daily newsletter. 12/31/20235,220,000 shares $323.64 million +3.6%7.8%4.5 $62.00 12/15/20235,040,000 shares $383.24 million +3.3%7.5%4.2 $76.04 11/30/20234,880,000 shares $349.51 million +2.7%7.3%4.9 $71.62 11/15/20234,750,000 shares $324.81 million -1.9%7.1%5.1 $68.38 10/31/20234,840,000 shares $312.66 million +8.0%7.2%4.9 $64.60 10/15/20234,480,000 shares $302.27 million -8.6%6.7%4.2 $67.47 9/30/20234,900,000 shares $340.45 million -2.2%7.3%4.6 $69.48 9/15/20235,010,000 shares $324.70 million -3.7%7.5%5 $64.81 8/31/20235,200,000 shares $355.89 million -2.3%7.8%5.2 $68.44 8/15/20235,320,000 shares $364.15 million +17.2%7.9%5 $68.45 7/31/20234,540,000 shares $392.66 million -8.1%6.8%4.3 $86.49 7/15/20234,940,000 shares $425.28 million -4.6%7.4%4.8 $86.09 6/30/20235,180,000 shares $434.71 million +11.4%7.8%5.1 $83.92 6/15/20234,650,000 shares $417.62 million +26.4%7.0%4.5 $89.81 5/31/20233,680,000 shares $318.65 million +8.6%5.5%3.6 $86.59 5/15/20233,390,000 shares $336.32 million -6.9%5.1%3.2 $99.21 4/30/20233,640,000 shares $311.04 million +4.6%5.5%3.4 $85.45 4/15/20233,480,000 shares $308.57 million -0.6%5.3%3.6 $88.67 3/31/20233,500,000 shares $288.96 million +2.3%5.3%3.5 $82.56 3/15/20233,420,000 shares $250.48 million -8.1%5.2%3.4 $73.24 2/28/20233,720,000 shares $275.13 million +32.9%5.6%3.3 $73.96 2/15/20232,800,000 shares $168.08 million -12.5%4.2%2.6 $60.03 1/31/20233,200,000 shares $184 million -7.3%4.8%2.9 $57.50 1/15/20233,450,000 shares $183.13 million -5.5%5.1%3.1 $53.08 12/30/20223,650,000 shares $186.00 million +3.1%5.4%2.7 $50.96 12/15/20223,540,000 shares $186.63 million +91.4%5.3%2.5 $52.72 11/30/20221,850,000 shares $114.85 million -28.6%2.7%1.3 $62.08 11/15/20222,590,000 shares $152.94 million -20.3%3.9%2 $59.05 10/31/20223,250,000 shares $240.47 million -12.9%4.8%2.6 $73.99 10/15/20223,730,000 shares $256.77 million +9.7%5.6%2.9 $68.84 9/30/20223,400,000 shares $239.12 million +13.7%5.1%2.5 $70.33 9/15/20222,990,000 shares $248.35 million +5.7%4.5%2.7 $83.06 8/31/20222,830,000 shares $223.00 million +7.6%4.2%2.4 $78.80 8/15/20222,630,000 shares $220.13 million -0.8%3.9%2.2 $83.70How to camouflage a factory of 53,000 workers (Ad)"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. LNTH Short Interest - Frequently Asked Questions What is Lantheus' current short interest? Short interest is the volume of Lantheus shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 4,720,000 shares of LNTH short. 7.05% of Lantheus' shares are currently sold short. Learn More on Lantheus' current short interest. What is a good short interest ratio for Lantheus? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LNTH shares currently have a short interest ratio of 4.0. Learn More on Lantheus's short interest ratio. Which institutional investors are shorting Lantheus? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lantheus: Wells Fargo & Company MN, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Lantheus? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.05% of Lantheus' floating shares are currently sold short. Is Lantheus' short interest increasing or decreasing? Lantheus saw a decrease in short interest in March. As of March 31st, there was short interest totaling 4,720,000 shares, a decrease of 8.9% from the previous total of 5,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lantheus' float size? Lantheus currently has issued a total of 68,551,000 shares. Some of Lantheus' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lantheus currently has a public float of 66,920,000 shares. How does Lantheus' short interest compare to its competitors? 7.05% of Lantheus' shares are currently sold short. Here is how the short interest of companies compare to Lantheus: QuidelOrtho Co. (3.36%), Neogen Co. (7.71%), Celldex Therapeutics, Inc. (11.74%), Intellia Therapeutics, Inc. (15.38%), Riot Platforms, Inc. (12.31%), Myriad Genetics, Inc. (6.27%), Alpine Immune Sciences, Inc. (8.05%), Merit Medical Systems, Inc. (3.41%), Haemonetics Co. (4.06%), Nuvalent, Inc. (20.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Lantheus stock? Short selling LNTH is an investing strategy that aims to generate trading profit from Lantheus as its price is falling. LNTH shares are trading up $1.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lantheus? A short squeeze for Lantheus occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LNTH, which in turn drives the price of the stock up even further. How often is Lantheus' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LNTH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: QuidelOrtho Short Interest Data Neogen Short Interest Data Celldex Therapeutics Short Interest Data Intellia Therapeutics Short Interest Data Riot Platforms Short Interest Data Myriad Genetics Short Interest Data Alpine Immune Sciences Short Interest Data Merit Medical Systems Short Interest Data Haemonetics Short Interest Data Nuvalent Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LNTH) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders